Epigenetic Modulation of Self-Renewal Capacity of Leukemic Stem Cells and Implications for Chemotherapy
Most patients with acute myeloid leukemia (AML) have a poor prognosis. Curative therapy of AML requires<i> </i>the complete eradication of the leukemic stem cells (LSCs). One aspect of LSCs that is poorly understood is their low frequency in the total population of leukemic cells in AML...
Main Authors: | Richard L. Momparler, Sylvie Côté, Louise F. Momparler |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-03-01
|
Series: | Epigenomes |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4655/4/1/3 |
Similar Items
-
Enhancement of the Antileukemic Action of the Inhibitors of DNA and Histone Methylation: 5-Aza-2′-Deoxycytidine and 3-Deazaneplanocin-A by Vitamin C
by: Richard L. Momparler, et al.
Published: (2021-03-01) -
Pharmacokinetic and pharmacodynamic analysis of 5-aza-2’-deoxycytidine (decitabine) in the design of its dose-schedule for cancer therapy
by: Karahoca Metin, et al.
Published: (2013-02-01) -
A Perspective on the Comparative Antileukemic Activity of 5-Aza-2′-deoxycytidine (Decitabine) and 5-Azacytidine (Vidaza)
by: Richard L. Momparler
Published: (2012-08-01) -
Reciprocal epigenetic remodeling controls testicular cancer hypersensitivity to hypomethylating agents and chemotherapy
by: Ratnakar Singh, et al.
Published: (2022-02-01) -
LRWD1 expression is regulated through DNA methylation in human testicular embryonal carcinoma cells
by: Jui-Hsiang Hung, et al.
Published: (2021-05-01)